Gw Pharmaceuticals Plc Stock Operating Margin
GW Pharmaceuticals Plc fundamentals help investors to digest information that contributes to GW Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of GWPRF OTC Stock. The fundamental analysis module provides a way to measure GW Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to GW Pharmaceuticals otc stock.
GWPRF |
GW Pharmaceuticals Plc OTC Stock Operating Margin Analysis
GW Pharmaceuticals' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current GW Pharmaceuticals Operating Margin | (11.73) % |
Most of GW Pharmaceuticals' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GW Pharmaceuticals Plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
CompetitionBased on the recorded statements, GW Pharmaceuticals Plc has an Operating Margin of -11.73%. This is much lower than that of the sector and significantly lower than that of the Operating Margin industry. The operating margin for all United States stocks is notably higher than that of the company.
GWPRF Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GW Pharmaceuticals' direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of GW Pharmaceuticals could also be used in its relative valuation, which is a method of valuing GW Pharmaceuticals by comparing valuation metrics of similar companies.GW Pharmaceuticals is currently under evaluation in operating margin category among related companies.
GWPRF Fundamentals
| Return On Equity | -9.62 | |||
| Return On Asset | -4.58 | |||
| Profit Margin | (12.49) % | |||
| Operating Margin | (11.73) % | |||
| Current Valuation | 120.65 M | |||
| Shares Outstanding | 378.54 M | |||
| Shares Owned By Insiders | 1.99 % | |||
| Shares Owned By Institutions | 13.60 % | |||
| Price To Earning | 10.80 X | |||
| Price To Book | 0.73 X | |||
| Price To Sales | 11.51 X | |||
| Revenue | 559.04 M | |||
| Gross Profit | 489.67 M | |||
| EBITDA | (51.65 M) | |||
| Net Income | (69.84 M) | |||
| Cash And Equivalents | 458.1 M | |||
| Cash Per Share | 14.52 X | |||
| Total Debt | 42.5 M | |||
| Debt To Equity | 0.06 % | |||
| Current Ratio | 4.49 X | |||
| Book Value Per Share | 23.35 X | |||
| Cash Flow From Operations | (20.51 M) | |||
| Earnings Per Share | (2.22) X | |||
| Number Of Employees | 1.16 K | |||
| Beta | 1.65 | |||
| Market Capitalization | 6.44 B | |||
| Total Asset | 453 M | |||
| Retained Earnings | (178 M) | |||
| Working Capital | 370 M | |||
| Current Asset | 405 M | |||
| Current Liabilities | 35 M | |||
| Z Score | 91.6 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards GW Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, GW Pharmaceuticals' short interest history, or implied volatility extrapolated from GW Pharmaceuticals options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in GWPRF OTC Stock
If you are still planning to invest in GW Pharmaceuticals Plc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the GW Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |